Abstract
No public abstract is available from the verified source records.
Bingun Habarakadage, Sabari Rajendran, Chao An, Sahadev Khadka, Morgan J. Anderson, Jessica Koehne, Duy H. Hua
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Site-selective cleavage of peptides and proteins targeting aromatic amino acid residues
10.1039/d4ra08956a · 2025
Diagnostic and therapeutic potential of protease inhibition
10.1016/j.mam.2022.101144 · 2022
Inflammation, extracellular matrix remodeling, and proteostasis in tumor microenvironment
10.3390/ijms22158102 · 2021
Extracellular proteolysis in cancer: proteases, substrates, and mechanisms in tumor progression and metastasis
10.1016/j.jbc.2024.107347 · 2024
Cysteine cathepsins: from structure, function and regulation to new frontiers
10.1016/j.bbapap.2011.10.002 · 2012
Cysteine cathepsins and their extracellular roles: shaping the microenvironment
10.3390/cells8030264 · 2019
The roles of matrix metalloproteinases and their inhibitors in human diseases
10.3390/ijms21249739 · 2020
Insights into the role of matrix metalloproteinases in cancer and its various therapeutic aspects: a review
10.3389/fmolb.2022.896099 · 2022
Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response
10.1038/nrc4027 · 2015
unpaywall
Confidence 95%
datacite
Confidence 0%
ADAM proteases in cancer: biological roles, therapeutic challenges, and emerging opportunities
10.3390/cancers17101703 · 2025
Novel ELISA for the specific detection of protease NEXIN-1 in human biological samples
10.1002/rth2.12756 · 2022
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer
10.1038/bjc.1995.197 · 1995
Peptide probes for proteases - innovations and applications for monitoring proteolytic activity
10.1039/d1cs00798j · 2022
Discovery of Leishmania druggable serine proteases by activity-based protein profiling
10.3389/fphar.2022.929493 · 2022
Recent advances in activity-based probes (ABPs) and affinity-based probes (A BPs) for profiling of enzymes
10.1039/d1sc01359a · 2021
Micro/Nano electrode array sensors: advances in fabrication and emerging applications in bioanalysis
10.3389/fchem.2020.573865 · 2020
Trends and recent development of the microelectrode arrays (MEAs)
10.1016/j.bios.2020.112854 · 2021
Recent developments in protease activity assays and sensors
10.1039/c6an02647h · 2017
Electrochemical biosensors
10.1039/b714449k · 2010
Electrochemical protease biosensor based on enhanced AC voltammetry using carbon Nanofiber Nanoelectrode arrays
10.1021/jp312031u · 2013
Simultaneous, multiplex quantification of protease activities using a gold microelectrode array
10.1016/j.bios.2020.112330 · 2020
Quantitative detection of cathepsin B activity in neutral pH buffers using gold microelectrode arrays: toward direct multiplex analyses of extracellular proteases in human serum
10.1021/acssensors.1c01175 · 2021
Mitigating dithiothreitol interference to gold/thiol interface in electrochemical detection of cathepsin B activity toward multiplex protease analysis
2025
Rapid and sensitive detection of the activity of ADAM17 using a graphene oxide-based fluorescence sensor
10.1039/c8an02344a · 2019
Optimization of fluorescent substrates for ADAM17 and their utility in the detection of diabetes
10.1016/j.ab.2023.115337 · 2023
Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples
10.1039/c9sc00997c · 2019
JG26 attenuates ADAM17 metalloproteinase-mediated ACE2 receptor processing and SARS-CoV-2 infection in vitro
10.1007/s43440-024-00650-0 · 2025
Electrochemical proteolytic beacon for detection of matrix metalloproteinase activities
10.1021/ja0626638 · 2006
Sensors and regulators of intracellular pH
10.1038/nrm2820 · 2010
Glucose dependent insulinotropic polypeptide and dipeptidyl peptidase inhibitors: their roles in management of type 2 diabetes mellitus
10.1016/j.dsx.2016.03.013 · 2016
Cathepsin B Dipeptidyl carboxypeptidase and endopeptidase activities demonstrated across a broad pH range
10.1021/acs.biochem.2c00358 · 2022
Distinct cleavage properties of cathepsin B compared to cysteine cathepsins enable the design and validation of a specific substrate for cathepsin B over a broad pH range
10.1021/acs.biochem.3c00139 · 2023
Multiplex substrate profiling by mass spectrometry for proteases
10.1016/bs.mie.2022.09.009 · 2023
Unresolved referenced work
2009
Harnessing protein sensing ability of electrochemical biosensors via a controlled peptide receptor-electrode interface
10.1186/s12951-023-01843-0 · 2023
Towards rational computational peptide design
10.3389/fbinf.2022.1046493 · 2022
Leveraging machine learning models for peptide-protein interaction prediction
10.1039/d3cb00208j · 2024
Cathepsin B
10.1016/s1357-2725(96)00152-5 · 1997
Role of the occluding loop in cathepsin B activity
10.1074/jbc.272.2.1197 · 1997
Lysosomal cysteine proteases: facts and opportunities
10.1093/emboj/20.17.4629 · 2001
Substrate specificity of cysteine proteases beyond the S(2) pocket: mutagenesis and molecular dynamics investigation of Fasciola hepatica cathepsins L
10.3389/fmolb.2018.00040 · doi-reference
Specificity determinants of human cathepsin s revealed by crystal structures of complexes
10.1021/bi027308i · doi-reference
Inhibition of endogenous dentin matrix metalloproteinases by ethylenediaminetetraacetic acid
10.1016/j.joen.2011.09.005 · doi-reference
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
10.1002/jcc.21334 · doi-reference
CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting
10.1093/nar/gkac394 · doi-reference
ColabFold: making protein folding accessible to all
10.1038/s41592-022-01488-1 · doi-reference
Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: a basis for the design of specific epoxysuccinyl inhibitors
10.1021/bi00014a037 · doi-reference
Cathepsin B carboxydipeptidase specificity analysis using internally quenched fluorescent peptides
10.1042/bj20020840 · doi-reference
Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts
10.1021/bi971264+ · doi-reference
S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B
10.1042/bj3610613 · doi-reference
A summary of the measured pK values of the ionizable groups in folded proteins
10.1002/pro.19 · doi-reference
Cathepsin B: active site mapping with peptidic substrates and inhibitors
10.1016/j.bmc.2018.10.017 · doi-reference
Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides to define substrate specificity of carboxydipeptidases: assays with human cathepsin B
10.1016/j.ab.2004.09.012 · doi-reference
Fluorescence-quenched solid phase combinatorial libraries in the characterization of cysteine protease substrate specificity
10.1021/cc990031u · doi-reference
Characterization of the peptide substrate specificities of interstitial collagenase and 92-Kda gelatinase - implications for substrate optimization
10.1016/s0021-9258(20)30064-8 · doi-reference
Using peptide libraries to identify optimal cleavage motifs for proteolytic enzymes
10.1016/j.ymeth.2003.10.003 · doi-reference
Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library
10.1074/jbc.m004538200 · doi-reference
Cathepsin B: plasma expression and concentration in non-hodgkin lymphoma patients
10.3390/hemato6020013 · doi-reference
Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer
10.1177/172460080802300305 · doi-reference
Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer
10.2147/ott.s123042 · doi-reference
Fluorescent peptomer substrates for differential degradation by metalloproteases
10.1021/acs.biomac.2c01077 · doi-reference
Selective neutral pH inhibitor of cathepsin B designed based on cleavage preferences at cytosolic and lysosomal pH conditions
10.1021/acschembio.1c00138 · doi-reference
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
10.1101/gad.1874010 · doi-reference
Cathepsin B: multiple roles in cancer
10.1002/prca.201300105 · doi-reference
Cysteine cathepsins: multifunctional enzymes in cancer
10.1038/nrc1949 · doi-reference